UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2006, ISBN 9780309101004, xiv, 276
Book
1993, Basic and clinical oncology, ISBN 9780824787363, Volume 1, xv, 424
Book
The New England journal of medicine, ISSN 0028-4793, 01/2016, Volume 374, Issue 4, pp. 323 - 332
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Benzamides - pharmacokinetics | Humans | Middle Aged | Pyrazines - administration & dosage | Male | Antineoplastic Agents - administration & dosage | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Protein Kinase Inhibitors - adverse effects | Diarrhea - chemically induced | Dose-Response Relationship, Drug | Benzamides - administration & dosage | Antineoplastic Agents - adverse effects | Female | Antineoplastic Agents - pharmacokinetics | Benzamides - adverse effects | Headache - chemically induced | Chromosome Deletion | Protein Kinase Inhibitors - pharmacokinetics | Administration, Oral | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Agammaglobulinaemia Tyrosine Kinase | Pyrazines - pharmacokinetics | Pyrazines - adverse effects | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Antimitotic agents | Treatment outcome | Usage | Care and treatment | Safety and security measures | Lymphocytic leukemia | Analysis | Clinical trials | Pharmacology | Dosage and administration | Pharmacokinetics | Antineoplastic agents | Tyrosine | Headache | Pharmacodynamics | Transformation | Chronic lymphatic leukemia | Inhibitor drugs | Leukemia | Diarrhea | Chromosome deletion | Lymphatic leukemia | Kinases | Lymphoma | Bruton's tyrosine kinase | Patients | Clonal deletion | Safety | Drug therapy | Lymphocytosis | Protein-tyrosine kinase | Chromosome 17 | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 04/2018, Volume 391, Issue 10129, pp. 1524 - 1537
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Diagnosis, Differential | Genetic Predisposition to Disease | Pyrazoles - therapeutic use | Prognosis | Humans | Risk Factors | Leukemia, Lymphocytic, Chronic, B-Cell - etiology | Treatment Outcome | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Sulfonamides - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Pyrimidines - therapeutic use | Survival Analysis | Purines - therapeutic use | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Mutation | Quinazolinones - therapeutic use | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis | Monoclonal antibodies | Medical colleges | Chemotherapy | Cancer | Developed countries | Lymphatic system | Immunoglobulins | Chronic lymphatic leukemia | Bcl-2 protein | Laboratories | Research funding | Pathogenesis | Leukemia | Genes | Family medical history | Disease control | Patients | Lymphoma | Lymphocytes | Medical prognosis | CD20 antigen | Evolution & development | Chromosomes | Age | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 06/2008, Volume 111, Issue 12, pp. 5446 - 5456
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Leukemia, Lymphocytic, Chronic, B-Cell - therapy | Education | United States | Humans | Clinical Trials as Topic - standards | National Cancer Institute (U.S.) - standards | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis | Index Medicus | Abridged Index Medicus | Review
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2014, Volume 312, Issue 21, pp. 2265 - 2276
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Leukemia, Lymphocytic, Chronic, B-Cell - classification | Humans | Immunotherapy | Antineoplastic Agents - therapeutic use | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Neoplasm Staging | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis | Chemotherapy | Medical diagnosis | Leukemia | Medical treatment
Journal Article
American journal of hematology, ISSN 0361-8609, 03/2016, Volume 91, Issue 3, pp. 330 - 340
Life Sciences & Biomedicine | Hematology | Science & Technology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Molecular Targeted Therapy - methods | Chronic lymphocytic leukemia | Chemotherapy | Analysis | Immunotherapy | Monoclonal antibodies | Cytogenetics | Tumor proteins | Cancer | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2005, Volume 352, Issue 8, pp. 804 - 815
Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | T-Lymphocytes - physiology | Prognosis | Signal Transduction | Lymphocyte Activation | Humans | B-Lymphocytes - physiology | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Leukemia, Lymphocytic, Chronic, B-Cell - therapy | Cell Transformation, Neoplastic | Leukemia, Lymphocytic, Chronic, B-Cell - physiopathology | Receptors, Antigen, B-Cell - chemistry | Mutation | Neoplasm Staging | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Lymphocytic leukemia | Chronic lymphocytic leukemia | Research | Index Medicus | Abridged Index Medicus
Journal Article